The 22nd Annual Thomas J. Fogarty, MD Lecture: Focus on Innovation
Friday, October 30, 2020 | 4pm
LKSC – Berg Hall | Stanford University
Featuring Julio C. Palmaz, MD, radiologist, honorary Ashbel Smith Professor at the University of Texas Health Science Center, inventor, entrepreneur, and vintner.
The Fogarty lectureship was established to bring together a diverse community in Silicon Valley focusing on leaders in discovery, invention, innovation, and entrepreneurship. This event is sponsored by Stanford Byers Center for Biodesign, Fogarty Institute for Innovation and Stanford Department of Surgery. Watch this space for more information.
Presented by Dr. Arden Morris, MD
Professor of Surgery (General Surgery)
S-SPIRE Director
Stanford University Medical Center
Bio
Arden M. Morris, MD, MPH is professor and vice chair of clinical research in the Department of Surgery, director of the Stanford-Surgery Policy, Improvement Research and Education (S-SPIRE) Center, and core faculty in the Stanford Department of Health Research and Policy. Dr. Morris joined Stanford in 2016 from the University of Michigan where she was an associate professor and division chief of colorectal surgery. In her research, she uses mixed methods to focus on improving quality and equity in surgical care. She has deployed her expertise in a number of leadership and advisory roles and policy panels such as National Quality Forum’s Consensus Standards and Approval Committee and the Medicare Coverage Advisory Committee.
Christopher Stave
INFORMATION SERVICES LIBRARIAN, SCHOOL OF MEDICINE – LANE MEDICAL LIBRARY
Mir Imran has accepted the invitation to be the 24th annual Fogarty guest lecturer. The date of the event is Friday September 30, 2022 at 4pm. It will be a hybrid event.
Mir Imran, Chairman & CEO of InCube Labs, is a prolific healthcare innovator and entrepreneur, who has been developing and commercializing breakthrough medical innovations for over 40 years.
Mir began his career as a healthcare entrepreneur in the late 1970’s with his pioneering contributions to the first FDA-approved Implantable Defibrillator (ICD). Since then, Mir has founded more than 20 life sciences companies and two tech companies, 15 of which have seen liquidity events (IPO/Acquisition). His most recent exit, Rani Therapeutics Holdings Inc., went public on Nasdaq in July 2021.
Mir’s inventions have saved the lives of millions of patients, and many have become the standards of care. He has developed innovative therapies for a number of chronic diseases, including, anemia, chronic pain, stroke, diabetes, and several cardiovascular conditions. His recent company, Rani Therapeutics, is revolutionizing the management of chronic diseases, by replacing painful injectable therapies with oral biologics.
Mir holds more than 800 issued & pending US patents. In 2016, QMed named Mir as one of the “Top 50 Medical Inventors of All Time”. Mir is a fellow of the National Academy of Engineering, the National Academy of Inventors and the American Institute of Medical & Biological Engineers. In 2009, Mir was inducted into the Rutgers University Hall of Distinguished Alumni.
Mir is also the co-founder & managing director of InCube Ventures, LP, a medtech/biotech venture capital fund. In addition, Mir serves on the boards of several life science companies, on the advisory board of the Lemelson Foundation, and is a trustee of the UCSC Foundation. He is also an Adjunct Professor of Bioengineering at the University of Pittsburgh and actively supports the promotion and teaching of innovation and entrepreneurship at colleges and universities. As a philanthropist, Mir is passionately supporting education in India and US, especially for underprivileged students.
Presented by:
Laura Graham, PhD
Health Services Research Economist
Stanford-Surgery Policy Improvement Research and Education Center
Bio
Laura is a health services researcher with a wide variety of experience in data management and analysis, including large multi-center health services and outcomes research studies, provider survey studies, and laboratory-oriented research. Her research interest includes surgical outcomes research, informatics, and implementation science to translate evidence into practice. The bulk of her research experience is centered around the use and analysis of large administrative datasets collected by the Veterans Health Administration. She has been involved in a multitude of Health Services Research & Development funded and unfunded studies using these administrative data to assess surgical outcomes.
General Surgery Former PD Resident:
Dr. Kirbi Yelorda
Dr. Jeff Choi
Dr. Wilson Alobuia
